"Puerto Rico Pharmaceuticals & Healthcare Report Q4 2012" Now Available at Fast Market Research
Slow economic recovery and the continued need for fiscal austerity means the development of Puerto Rico's overall healthcare spending will fall below its historic levels, as the government also looks to unload some of the costs to the private sector. While the territory will continue to be a major exporter of pharmaceuticals, its status will increasingly be challenged by emerging manufacturing locations in Asia and Latin America. Additionally, high-profile criticism of several plants in Puerto Rico by the US Food...
View full press release